AFFIMED THERAPEUTICS, AG
Patent Owner
Stats
- 4 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Jul 25, 2013 most recent publication
Details
- 4 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 179 Total Citation Count
- Oct 04, 2002 Earliest Filing
- 5 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8455627 Human antibody specific for activated state of platelet integrin receptor GPIIb/IIIaSep 07, 10Jun 04, 13[C07K]
7901677 Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer typesApr 05, 06Mar 08, 11[A61K]
7812136 Antibody of human origin specifically binding to activated state of platelet integrin receptor GPIIb/IIIaOct 04, 02Oct 12, 10[C07K]
7507797 Single-chain antibody acting against 37 kDa/67 kDa Iaminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereofOct 08, 04Mar 24, 09[A61K, C12N, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2008/0145,362 ANTIBODY COMBINATION USEFUL FOR TUMOR THERAPYAbandonedFeb 23, 08Jun 19, 08[A61K, C12P, C12N, A61P, C07K]
2006/0233,787 Human cd3-specific antibody with immunosuppressive propertiesAbandonedSep 10, 03Oct 19, 06[A61K, C07H, C12P, C12N, C07K]
2005/0176,934 Antibody combination useful for tumor therapyAbandonedApr 21, 05Aug 11, 05[A61K, C07K]
2005/0089,519 Bispecific anti-cd19x anti-cd16 antibodies and uses thereofAbandonedOct 25, 04Apr 28, 05[A61K, C07K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.